Zhejiang University

This study tested whether adding a low-dose drug called chidamide after a stem cell transplant could help prevent cancer from returning in patients with T-cell leukemia or lymphoma. It involved 44 patients who had already received a transplant and were in remission but at high ri…

This study tested whether a combination of two drugs, donafenib and an anti-PD-1 antibody, could safely prevent liver cancer from returning after surgery. It involved 30 patients who had their tumors removed but were at high risk of the cancer coming back. The goal was to see if …

This study tested if adding an immunotherapy drug (Anti-PD-1 antibody) to standard chemotherapy (modified-FOLFIRINOX) could help patients with borderline or locally advanced pancreatic cancer. It involved 392 participants who were randomly assigned to receive either the standard …

This early-stage study tested a new CAR-T cell therapy called ThisCART19A in 10 adults with B-cell acute lymphoblastic leukemia (B-ALL) that had returned or stopped responding to other treatments. The main goal was to check the safety of the treatment and see how the body handles…

This study tested whether creating a 3D map of the prostate from medical scans could help doctors perform more accurate biopsies. Researchers worked with 436 patients who needed a prostate biopsy due to suspicious areas seen on scans. They used special software to build a 3D mode…

This study tested whether a special high-flow nasal oxygen device could help prevent low oxygen levels during sedated endoscopy procedures. It focused on 80 patients at high risk for obstructive sleep apnea who were undergoing stomach or colon exams. Researchers compared breathin…

Hypoxia represents the prevailing adverse occurrence during the sedation of patients undergoing fiberoptic bronchoscopy with propofol. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bit…